Page 1 of 17
Class Progress
Page 4 of 20
Chapter Listing

Iron Infusion for the Treatment of Iron Deficiency Anemia - DEMO

Preview

Chapter 1: Introduction

Iron deficiency anemia is common among certain groups of people and oral iron supplementation is not appropriate for some of these. Intravenous iron infusions can significantly increase the quality of life for individuals suffering from this exhausting condition but are also associated with potentially serious complications. Research and development are providing more effective preparations associated with decreased risks. This instructional course has been designed to provide current conceptual and operational knowledge to healthcare professionals interested in the provision of parenteral iron to patients with iron deficiency anemia. For the healthcare professional involved in the treatment of these patients, this course contains current practices for best patient outcomes.

State Boards of Nursing have varying positions on the role of the LPN/LVN in the administration of infusion therapy. A link to each state board of nursing is listed here. Competency requirements are obtained and maintained through the nurse’s employer, facility or institution.

Objectives:

Upon completion of this course, the participant should be able to:

  1. Describe 3 symptoms of iron deficiency anemia.
  2. Identify 3 parenteral iron preparations.
  3. Demonstrate understanding of parenteral iron administration by recognizing the steps involved in its administration.
  4. Recognize at least two potential complications of iron administration.

Curriculum:

Chapter 1: Introduction

  • Functions of Iron
  • Iron Regulation
  • Causes of Iron Deficiency
  • Iron Deficiency Symptoms
  • Indications for Parenteral Iron Therapy

Chapter 2: Parenteral Iron Preparations

  • Ferric carboxymaltose (Injectafer®)
  • Ferric gluconate (Ferrlicet®)
  • Ferumoxytol (Feraheme®)
  • Iron sucrose (Venofer®)
  • Low molecular weight iron dextran (INFeD®)
  • Ferric pyrophosphate citrate (Triferic®)
  • Ferric derisomaltose (Monoferric®)

Chapter 3: Administration

Chapter 4: Hypersensitivity Reactions

Chapter 5: Patient Education and Documentation

Chapter 6: Bibliography


Page 1 of 17